Troels Lillebaek
@tlillebaek.bsky.social
Professor infectious Disease | focus molecular epidemiology | Global Health Section | Uni. of Copenhagen. Director | Int. Reference Lab. of Mycobacteriology | Statens Serum Institut | Copenhagen | DK. TB/NTM, Infection, transmission & control | Own views
📸 This is what #ESM2026 looked like! 214 participants from 42 countries, together in Verona for four days of science, ideas and connection. This is our community. Thank you to every one of you for making it so special. Until next time! 🧫 #ESMyco #Mycobacteriology
More on 🔬 day 2 of #ESM2026 in Verona! great sessions: TB Short Regimens in Trials, New Diagnostic Strategies for TB & NTM, and New Diagnostics for MDR-TB. Plus Poster Session 1 and a traditional dinner to close. Thanks to all speakers & chairs! See you for Day 3 🔬 #ESMyco #Tuberculosis
Congratulations to Bouke de Jong, winner of the Gardner Middlebrook Award at #ESM2026!
European Society of Mycobacteriology@esmyco.bsky.social · 2mo ago🏆 Congratulations to Bouke de Jong, winner of the Gardner Middlebrook Award at #ESM2026! One of the highest honours in our community, awarded for an outstanding career and lasting impact on mycobacteriology. A privilege to celebrate it in Verona. Huge congrats, Bouke 👏 #ESM26 #ESMyco
In one hour we will be 220 participants from 42 countries! The scientific highlight of the year for everyone interested in #mycobacteria is about to start. The 46th Annual Congress of the European Society of Mycobacteriology (ESM) will take place in Verona, Italy. #ESMyco #ESMyco2026
Fluoroquinolone monotherapy as #tuberculosis #preventice #therapy (TPT) to contacts exposed to multidrug-resistant TB (#MDRTB). New systematic review and meta-analysisis indicates that it´s safe. The article includes a nice overview over included studies, read: journals.theunion.org/content/ijtl...
journals.theunion.org
The scientific highlight for everyone interested in #mycobacteria is approaching fast. The 46th Annual Congress of the European Society of Mycobacteriology (ESM) will take place in Verona, Italy, 22–25 June 2026. The detailed programme is now available online (see below) #ESMyco2026
Medvirker i denne lille artikel om "Hvad skal du gøre, hvis du bliver smittet med #tuberkulose i forbindelse med arbejde? Og hvad er tuberkulose overhovedet? Det får du svar på i denne guide." fagbladetfoa.dk/arbejdsmiljo...
Tuberkulose som en arbejdsskade? Få svaret på det og meget mere her
Hvad skal du gøre, hvis du bliver smittet med tuberkulose i forbindelse med arbejde? Og hvad er tuberkulose overhovedet? Det får du svar på i denne guide.
fagbladetfoa.dk
Interesting article. Pretomanid remains the preferred component of the BPaL regimen but it seems delamanid could be a viable alternative if clinical reasons to substitute, including drug resistance or if pretomanid is unavailable or poorly tolerated. Read on: pubmed.ncbi.nlm.nih.gov/42053462/
Pretomanid vs delamanid in a bedaquiline-linezolid regimen: efficacy in a high-burden tuberculosis mouse model - PubMed
The bedaquiline, pretomanid, and linezolid (BPaL) regimen has shown significant efficacy in treating patients with multidrug-resistant and extensively drug-resistant tuberculosis. This study assessed ...
pubmed.ncbi.nlm.nih.gov
The European Society of Mycobacteriology (ESM) annual scientific congress in Verona 2026 is approaching. Given Verona's popularity as a tourist destination, and the fact that our congress coincides with the opera festival, register and book accommodation ASAP. www.linkedin.com/posts/troels...
Current meeting | ESM | Troels L.
The European Society of Mycobacteriology (ESM) annual scientific congress in Verona 2026 is approaching. Given Verona's popularity as a tourist destination, and the fact that our congress coincides wi...
linkedin.com
Infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized worldwide, yet the long-term epidemiology of these human pathogens remains poorly understood.
#tuberkulose på 10 minutter? Sygdommen hvor vi allerede har effektiv diagnostik og behandling - men tilsyneladende ikke viljen til at udrydde den fattigdom der gør, at tuberkulose fortsat er den største dræber i verden som følge af en enkelt mikroorganisme.
Tuberkulose: Den mest dødelige sygdom, som vi har glemt | Troels L.
Lær om tuberkulose på 10 minutter? Sygdommen hvor vi allerede har effektiv diagnostik og behandling - men tilsyneladende ikke viljen til at udrydde den fattigdom der gør, at tuberkulose fortsat er den...
linkedin.com
Today, on World TB Day, marking the date when Robert Koch announced the discovery of Mycobacterium tuberculosis, the European Society of Mycobacteriology reaffirms its commitment to advancing science, research, and education in the field of mycobacteriology. Read on: www.linkedin.com/pulse/europe...
linkedin.com
www.linkedin.com/posts/troels...
Reserver dagene: 23-25 november 2026 afholder Afdeling for Tuberkulose og Mykobakterier på SSI intensivt kursus i mykobakteriologi (tuberkulose og non-tuberkuløse mykobakterier). Emnerne er… | Troels ...
Reserver dagene: 23-25 november 2026 afholder Afdeling for Tuberkulose og Mykobakterier på SSI intensivt kursus i mykobakteriologi (tuberkulose og non-tuberkuløse mykobakterier). Emnerne er diagnostik...
linkedin.com
#Tuberculosis (TB) among #refugee #minors in low-incidence countries? In this article we estimated the incidence of TB disease among refugee minors compared to Danish-born. There is a need for national policies and clinical guidelines, read: pubmed.ncbi.nlm.nih.gov/41689350/
High Tuberculosis Incidence Among Refugee Minors in Denmark: A Register-Based Cohort Study - PubMed
Our findings underscore the need for national policies and clinical guidelines for TB screening of all refugee minors upon arrival to reduce morbidity and advance TB elimination efforts.
pubmed.ncbi.nlm.nih.gov
#Eliminering af #tuberkulose i #Danmark ? I ny statusartikel i Ugeskrift for Læger sætter Isik Somuncu Johansen, Pernille Ravn, Andreas Fløe, Anders Koch, Christian Wejse & undertegnede fokus på, hvor Danmark står i forhold til WHO’s mål om tuberkulose-elimination. www.linkedin.com/posts/troels...
Eliminering af tuberkulose i Danmark | Troels L.
Ny statusartikel i Ugeskrift for Læger: #Eliminering af #tuberkulose i #Danmark ? I en netop publiceret statusartikel i Ugeskrift for Læger sætter Isik Somuncu Johansen, Pernille Ravn, Andreas Fløe, A...
linkedin.com
#Tuberkulose og #ulighed er tæt forbundet: Jeg kan varmt anbefale en ny statusartikel om social ulighed i sundhed skrevet af Finn Diderichsen i Ugeskrift for Læger. Se min anbefaling på LinkedIn www.linkedin.com/posts/troels...
Ulighedens grammatik | Troels L.
#Tuberkulose og #ulighed er tæt forbundet: Jeg kan varmt anbefale denne nye statusartikel om social ulighed i sundhed skrevet af Finn Diderichsen i Ugeskrift for Læger. Artiklen giver et præcist beg...
linkedin.com
ECDC just updated "Handbook on tuberculosis #laboratory #diagnostic methods in EU". The update includes a new chapter on “The diagnosis of #nontuberculous #mycobacteria (NTM)”, recognising these increasing and difficult-to-treat mycobacteria. Read on in capter 11 from page 126:
ecdc.europa.eu
Thanks to all participants for a fantastic meeting with focus on all aspects of #mycobacteriology at #ESMyco2025
European Society of Mycobacteriology@esmyco.bsky.social · last yr.And that's a wrap on #ESM2025! A huge thank you to our incredible community of scientists, speakers, and organizers who made this week unforgettable. The future of mycobacteriology is bright! See you all in 2026! 👋 #Tuberculosis #Science
Great presentation from Xenia at #esm2025 supported by @micronorman.bsky.social and @tlillebaek.bsky.social and others on decades of NTM isolates from patients and how it changes over those years.
A huge congratulations to @jodyphelan.bsky.social from @lshtm.bsky.social l for receiving the Gertrud Meissner Award at #ESM2025! 🏆 His work on bioinformatic pipelines to predict drug resistance is truly impactful. Well deserved! 🎉 #Tuberculosis #Awards #Science
The prestigious Gardner Middlebrook Award is presented to Brigitte Gicquel from @pasteur.fr at #ESM2025. 🏆 Congratulations on this incredible honor, recognizing your immense contributions to our understanding of TB genetics and virulence. 👏 #Mycobacteriology
How to #treat #TB patients with #expanded #resistance to one or more of bedaquiline, linezolid, a third-generation fluoroquinolone, a nitroimidazole (pretomanid or delamanid, and/or clofazimine? Clinical experts elaborates best clinical practices, read on: pmc.ncbi.nlm.nih.gov/articles/PMC...
Clinical best practices for caring for people with expanded resistance to newer TB drugs
Strains of Mycobacterium tuberculosis with resistance to the new and repurposed drugs included in the all-oral shorter TB regimens recommended by WHO for the treatment of multidrug-resistant/rifampici...
pmc.ncbi.nlm.nih.gov
Join course "Optimising Management of TB and Mycobacterial Infections with Genomic Approaches". For mycobacteriology experts and young clinicians. Ideally, candidate trainees should be involved in implementation of NGS technologies for clinical management of TB & other mycobacterial diseases / NTM
Optimising Management of Tuberculosis and Mycobacterial Infections with Genomic Approaches
escmid-foundation.org
New review study from colleagues, On the way to #tuberculosis #elimination, expanded #contact #tracing including additional subgroups may play a role. Perhaps first, let us make sure contact tracing is performed systematically in already recommended groups/populations? doi.org/10.5588/pha....
TB yields from expanded contact tracing investigations: Ingenta ConnectBACKGROUNDMETHODSRESULTSCONCLUSION
doi.org
Last chance to submit your abstract Monday. Join us at European Society of Mycobacteriology annual congress in Lisbon, Portugal 🔬 #ESMyco
European Society of Mycobacteriology@esmyco.bsky.social · last yr.⏰ Deadline extended! Final call to submit abstracts & travel-grant apps for the 45th ESM Congress (#ESM2025) in Lisbon—now 5 May 2025, 23:59 CET. No more extensions, so polish your mycobacteriology work and share it with the world! 🌍✨ Submit ➜ lnkd.in/e5GYMrgc #Mycobacteriology
Things can change fast. In UK, after > a decade of declining incidence, TB is once again on the rise. In 2024, 5,480 people fell ill with TB in England, an increase of 13% from 2023, marking the highest rise since 1970 and continuing a worrying trend from 2021.
doi.org
Facts and myths about measles - The Lancet Infectious Diseases www.thelancet.com/journals/lan...
Facts and myths about measles
It seems ironic that Robert F Kennedy Jr, one of the most prominent antivaccine activists, has been made Secretary of Health and Human Services in the USA while one of the largest recent measles outbr...
thelancet.com
It's World Tuberculosis Day,let's unite to stop TB in its tracks! 🚫🦠 Join us at the vibrant 45th Annual Congress of the European Society of Mycobacteriology in Lisbon (22-25 June 2025). Save the date, register today! 🎯 www.esmycobacteriology.eu/event-home #EndTB
